Apoptotic rates from B cells and PBMCs
| . | CD4 . | CD8 . | B . | NI . |
|---|---|---|---|---|
| Control | 5.0 (± 2.4)*** | 11.2 (± 10.1)** | 4.2 (± 3.4)* | 1.1 (± 0.4)** |
| VPA | 16.3 (± 10.0)*** | 40.7 (± 37.2)** | 10.9 (± 13.0)* | 1.6 (± 0.5)** |
| . | CD4 . | CD8 . | B . | NI . |
|---|---|---|---|---|
| Control | 5.0 (± 2.4)*** | 11.2 (± 10.1)** | 4.2 (± 3.4)* | 1.1 (± 0.4)** |
| VPA | 16.3 (± 10.0)*** | 40.7 (± 37.2)** | 10.9 (± 13.0)* | 1.6 (± 0.5)** |
The mean apoptotic rates (± standard deviation) were calculated from the data of Figure 3A (CD4+) and 3B (CD8+), from the B-cell population (B) and from noninfected (NI) PBMCs. The data were statistically compared with the Wilcoxon 2-tailed signed rank test. Note that, in contrast to the results of Figure 2, the data presented here were obtained with cryopreserved cells.
** and *** indicate levels of statistical significance.